Coalescence Partners Investment Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001759662

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedTechnology TiltHigh Turnover how tags are computed

Q2 2026 · 12 positions · Total reported value $340.58M · Top-10 concentration 93.1% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 38.5% · 1 new · 4 cut · 0 exited

Active Share (vs S&P 500): 89.5% · vs QQQ: 90.7% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, Coalescence Partners Investment Management, LP disclosed 12 equity positions with a combined reported value of $340.58M. The filing implies a focused portfolio: its ten largest positions account for 93.1% of reported value. HoldingsHub classifies the profile as Small / Focused / Technology Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were TSM ($91.61M), BX ($38.24M), NVDA ($30.98M). By sector, the heaviest allocations are Technology 44.1%, Financials 24.9%. Versus the prior quarter, allocation shifted toward Technology (+7.4pp), Health Care (+1.9pp) and away from Industrials (-1.6pp), Financials (-3.8pp).

Versus the prior quarter, Coalescence Partners Investment Management, LP opened 1 new positions, trimmed 4 and fully exited 0, a turnover rate of 38.5% of positions. The portfolio's overlap with the prior quarter was 85% of names.

The largest new positions opened in Q2 2026 were ASML ($27.50M).

Of the 1 positions fully exited versus the prior quarter, the largest were MLM ($18.08M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • ASML ASML HLDG NV · $27.50M

Fully Exited (vs previous quarter)

  • MLM MARTIN MARIETTA MATLS INC · prev qtr: $18.08M

Insider Transactions (Form 4)

Latest Coalescence Partners Investment Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Coalescence Partners Investment Management, LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 12 US equity positions with a combined value of $340.58M. HoldingsHub carries 11 quarters of its filings (Q4 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-118130 (status: Approved), registered 2020-02-28
  • Regulatory AUM (Form ADV): $428.36M as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 4 private funds, of which 1 hedge funds
  • Website: cp-im.com

Portfolio Structure

  • 12 positions · $340.58M reported value (Q2 2026)
  • Top 10 holdings = 93.1% of reported value
  • Largest position: TSM (TAIWAN SEMICONDUCTOR MANUFAC) at 26.9%
  • Average position size: $28.38M

Sector Tilt

  • Information Technology 44.1%
  • Financials 24.9%
  • Consumer Discretionary 13.6%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 new, 2 added, 9 reduced, 1 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: Coalescence Partners Investment Management appears to be rebalancing with a cautious approach, reducing exposure to several high-growth technology and financial stocks while increasing positions in some healthcare and industrials. This may indicate a preference for more stable, defensive sectors amidst market uncertainty. 2. Key Moves: - Added: ASML (semiconductor equipment manufacturer) and IDXX (animal health and diagnostic testing services). - Reduced: TSM (semiconductor manufacturer), NVDA (graphics processing units), BX (private equity and real estate investment), TDG (specialty metals and alloys), MCO (credit rating agency), SPGI (rating agency), and FICO (consumer credit reporting services). - Added Significantly: IDXX (healthcare), DHR (industrials). - Reduced Significantly: TSM (45.4% QoQ), NVDA (46.7% QoQ), MCO (49.6% QoQ), SPGI (52.4% QoQ), FICO (52.9% QoQ). 3. Portfolio Structure: - The portfolio appears to be active rather than passive, as it actively adjusts its holdings. - There is a significant bias towards technology and financials, with some exposure to industrials and healthcare. - The risk appetite seems moderate, with a focus on reducing high-growth, volatile stocks. 4. Per-Holding One-Liner: - TSM: TSM (Taiwan Semiconductor Manufacturing Company) - semiconductor manufacturer. Unverified. - BX: BX (Blackstone) - private equity and real estate investment. Unverified. - NVDA: NVDA (NVIDIA) - graphics processing units and data center products. Unverified. - ASML: ASML (ASML Holding NV) - semiconductor equipment manufacturer. Unverified. - TDG: TDG (Transdigm Group Inc) - aerospace and defense supplier. Unverified. - MCO: MCO (Moody's Corporation) - credit rating agency. Unverified. - SPGI: SPGI (S&P Global Inc) - credit rating agency. Unverified. - FICO: FICO (Fair Isaac Corporation) - consumer credit reporting services. Unverified. - DHR: DHR (DanaHER Corporation) - industrial supplier. Unverified. - IDXX: IDXX (Idexx Laboratories Inc) - animal health and diagnostic testing services. Unverified. 5. One-Sentence Style Summary: Coalescence Partners is adjusting its portfolio for stability, shifting away from volatile technology and financial stocks towards more defensive sectors such as healthcare and industrials.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Technology 44.1%
Financials 24.9%
Industrials 13.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 191.83K $91.61M 26.90%
26.90%
Reduce
2 324.97K $38.24M 11.23%
11.23%
Reduce
3 154.81K $30.98M 9.10%
9.10%
Reduce
4 13.82K $27.50M 8.07%
8.07%
New
5 19.35K $25.78M 7.57%
7.57%
Reduce
6 52.20K $23.64M 6.94%
6.94%
Reduce
7 56.03K $22.82M 6.70%
6.70%
Reduce
8 18.98K $22.67M 6.66%
6.66%
Reduce
9 103.79K $19.77M 5.80%
5.80%
Add
10 26.78K $14.10M 4.14%
4.14%
Add
11 34.52K $11.84M 3.48%
3.48%
Reduce
12 22.66K $11.64M 3.42%
3.42%
Reduce

FAQ

What did Coalescence Partners Investment Management, LP buy in 2026-Q2?

In its 2026-Q2 13F filing, Coalescence Partners Investment Management, LP reported 12 equity positions worth $340.58M in aggregate; its largest disclosed positions were TSM ($91.61M), BX ($38.24M), NVDA ($30.98M).

How large is Coalescence Partners Investment Management, LP's portfolio?

Coalescence Partners Investment Management, LP reported $340.58M of long equity holdings across 12 positions as of 2026-Q2. Top-10 holdings account for 93.1% of reported value.

What is Coalescence Partners Investment Management, LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/coalescence-partners-investment-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →